SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-122651
Filing Date
2024-04-29
Accepted
2024-04-29 16:48:51
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS d704617dars.pdf ARS 1120332
  Complete submission text file 0001193125-24-122651.txt   1544437
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36274 | Film No.: 24892035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)